T cell receptor (TCR) genes (TRA/TRD, TRB and TRG) reside in three regions on human chromosomes (14q11.2, 7q34 and 7p14, respectively) and pig chromosomes (7q15.3-q21, 18q11.3-q12 and 9q21-22, respectively). During the maturation of T cells, TCR genes are rearranged by site-specific recombination. Occasionally, interlocus recombination of different TCR genes takes place, resulting in chromosome rearrangements. It has been suggested that the absolute number of these "innocent" trans-rearrangements correlates with the risk of lymphoma. The aims of this work were to assess the frequencies of rearrangements with breakpoints in TCR genes in domestic pig lymphocytes and to compare these with the frequencies of corresponding rearrangements in human lymphocytes by using fluorescence in situ hybridization with chromosome painting probes. We show that frequencies of trans-rearrangements involving TRA/TRD locus in pigs are significantly higher than the frequency of translocations with breakpoints in TRB and TRG genes in pigs and the frequencies of corresponding trans-rearrangements involving TRA/TRD locus in humans. Complex structure of the pig TRA/TRD locus with high number of potential V(D)J rearrangements compared to the human locus may account for the observed differences. Furthermore, we demonstrated that trans-rearrangements involving pig TRA/TRD locus occur at lower frequencies in γδ T cells than in αβ T lymphocytes. The decrease of the frequencies in γδ T cells is probably caused by the absence of TRA recombination during maturation of this T cell lineage. High numbers of innocent trans-rearrangements in pigs may indicate a higher risk of T-cell lymphoma than in humans.

Department of Genetics and Reproduction Central European Institute of Technology Veterinary Research Institute Hudcova 70 621 00 Brno Czech Republic

Zobrazit více v PubMed

Ann Oncol. 1997;8 Suppl 2:45-8 PubMed

Mol Immunol. 2008 Jan;45(2):493-509 PubMed

Annu Rev Immunol. 1992;10:785-807 PubMed

Leuk Res. 2004 Dec;28(12):1281-6 PubMed

Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):439-41 PubMed

J Exp Med. 1990 Aug 1;172(2):409-18 PubMed

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12522-7 PubMed

Chromosome Res. 2007;15(6):807-13 PubMed

Immunol Today. 1991 Jan;12(1):30-4 PubMed

BMC Genomics. 2009 Apr 24;10:192 PubMed

Mol Immunol. 2009 Mar;46(6):1212-21 PubMed

BMC Genomics. 2010 Feb 09;11:100 PubMed

Mutat Res. 1999 Aug 18;444(2):393-403 PubMed

Vet Q. 2003 Mar;25(1):17-30 PubMed

Science. 1989 Sep 15;245(4923):1242-6 PubMed

Br J Haematol. 2000 Apr;109(1):201-10 PubMed

Immunogenetics. 2005 May;57(3-4):254-66 PubMed

J Immunol. 2006 May 15;176(10):5707-12 PubMed

Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5301-5 PubMed

Environ Mol Mutagen. 2002;40(2):85-92 PubMed

Int J Radiat Biol. 1994 Dec;66(6 Suppl):S97-108 PubMed

Cancer Genet Cytogenet. 1987 May;26(1):95-104 PubMed

J Immunol. 1991 Nov 1;147(9):3201-9 PubMed

Genomics. 1996 Sep 1;36(2):252-62 PubMed

Immunology. 1996 Sep;89(1):76-83 PubMed

FASEB J. 1989 Oct;3(12):2344-59 PubMed

Br J Haematol. 2001 Jun;113(4):1001-8 PubMed

Nucleic Acids Res. 2013 Apr;41(8):4535-48 PubMed

Mutat Res. 1988 May;199(1):215-20 PubMed

Cancer Genet Cytogenet. 1991 Oct 15;56(2):143-56 PubMed

Cytogenet Cell Genet. 2001;93(1-2):94-9 PubMed

Chromosome Res. 2002;10(7):571-7 PubMed

Dev Comp Immunol. 2009 Oct;33(10):1111-9 PubMed

Hum Genet. 1988 Jun;79(2):147-50 PubMed

J Exp Med. 2007 Jun 11;204(6):1371-81 PubMed

Vet Pathol. 1998 Mar;35(2):147-9 PubMed

DNA Repair (Amst). 2006 Sep 8;5(9-10):1246-58 PubMed

J Clin Invest. 1995 Dec;96(6):2744-7 PubMed

J Vet Med Sci. 2012 Feb;74(2):149-54 PubMed

Leukemia. 1992;6 Suppl 1:8-13 PubMed

Cancer Res. 1997 Oct 1;57(19):4408-13 PubMed

Cancer Genet Cytogenet. 1990 May;46(1):9-19 PubMed

Haematologica. 2013 Aug;98(8):1173-84 PubMed

J Exp Med. 1994 Nov 1;180(5):1685-91 PubMed

Am J Med Genet. 1989 Mar;32(3):425-31 PubMed